FDAFDA · Food and drugs·Recall number D-0579-2023
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,
Published May 24, 2023 · Recall initiated: May 9, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent: Low anti-factor IIa Potency.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HEPARIN SODIUM IN DEXTROSE
- Manufacturer
- B. Braun Medical Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot Number: J1P154N, Exp: 31 May, 2023,
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.